Roche Holding AG (RHHBF)
USD 303.32
(0.0%)
USD 303.32
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 30.78 Billion CHF | 15.97% |
| 2022 | 26.54 Billion CHF | -18.46% |
| 2021 | 32.55 Billion CHF | 111.23% |
| 2020 | 15.41 Billion CHF | -1.1% |
| 2019 | 15.58 Billion CHF | -16.98% |
| 2018 | 18.77 Billion CHF | -1.0% |
| 2017 | 18.96 Billion CHF | -15.19% |
| 2016 | 22.35 Billion CHF | -3.85% |
| 2015 | 23.25 Billion CHF | -9.58% |
| 2014 | 25.71 Billion CHF | 37.93% |
| 2013 | 18.64 Billion CHF | -24.18% |
| 2012 | 24.59 Billion CHF | -8.43% |
| 2011 | 26.85 Billion CHF | -10.66% |
| 2010 | 30.05 Billion CHF | -29.14% |
| 2009 | 42.41 Billion CHF | 937.32% |
| 2008 | 4.08 Billion CHF | -40.45% |
| 2007 | 6.86 Billion CHF | -16.71% |
| 2006 | 8.24 Billion CHF | -14.76% |
| 2005 | 9.67 Billion CHF | 7.92% |
| 2004 | 8.96 Billion CHF | -41.39% |
| 2003 | 15.28 Billion CHF | -31.6% |
| 2002 | 22.35 Billion CHF | -5.82% |
| 2001 | 23.73 Billion CHF | 9.77% |
| 2000 | 21.61 Billion CHF | -11.12% |
| 1999 | 24.32 Billion CHF | 20.97% |
| 1998 | 20.1 Billion CHF | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 34.44 Billion CHF | 0.0% |
| 2024 Q1 | 36.17 Billion CHF | 17.52% |
| 2023 Q2 | 25.38 Billion CHF | -4.36% |
| 2023 FY | 30.78 Billion CHF | 15.97% |
| 2023 Q3 | 30.55 Billion CHF | 20.38% |
| 2023 Q4 | 30.78 Billion CHF | 0.73% |
| 2023 Q1 | 26.54 Billion CHF | 0.0% |
| 2022 Q4 | 26.54 Billion CHF | 0.56% |
| 2022 FY | 26.54 Billion CHF | -18.46% |
| 2022 Q1 | 29.06 Billion CHF | -10.71% |
| 2022 Q2 | 27.75 Billion CHF | -4.53% |
| 2022 Q3 | 26.39 Billion CHF | -4.88% |
| 2021 Q4 | 32.55 Billion CHF | 0.96% |
| 2021 Q3 | 32.24 Billion CHF | 114.8% |
| 2021 Q2 | 15.01 Billion CHF | -7.54% |
| 2021 Q1 | 16.23 Billion CHF | 5.35% |
| 2021 FY | 32.55 Billion CHF | 111.23% |
| 2020 Q1 | 16.27 Billion CHF | 4.42% |
| 2020 FY | 15.41 Billion CHF | -1.1% |
| 2020 Q3 | 15.09 Billion CHF | 0.33% |
| 2020 Q4 | 15.41 Billion CHF | 2.11% |
| 2020 Q2 | 15.04 Billion CHF | -7.55% |
| 2019 Q3 | 15.24 Billion CHF | -22.12% |
| 2019 Q4 | 15.58 Billion CHF | 2.23% |
| 2019 FY | 15.58 Billion CHF | -16.98% |
| 2019 Q2 | 19.57 Billion CHF | -4.75% |
| 2019 Q1 | 20.54 Billion CHF | 9.47% |
| 2018 Q1 | 20.71 Billion CHF | 9.28% |
| 2018 Q3 | 18.79 Billion CHF | -9.3% |
| 2018 FY | 18.77 Billion CHF | -1.0% |
| 2018 Q2 | 20.71 Billion CHF | 0.0% |
| 2018 Q4 | 18.77 Billion CHF | -0.12% |
| 2017 Q4 | 18.96 Billion CHF | -0.09% |
| 2017 FY | 18.96 Billion CHF | -15.19% |
| 2017 Q3 | 18.97 Billion CHF | -10.13% |
| 2017 Q2 | 21.11 Billion CHF | 0.0% |
| 2017 Q1 | 21.11 Billion CHF | -5.55% |
| 2016 Q2 | 24.81 Billion CHF | 0.0% |
| 2016 Q1 | 24.81 Billion CHF | 6.72% |
| 2016 Q3 | 22.36 Billion CHF | -9.88% |
| 2016 Q4 | 22.35 Billion CHF | -0.03% |
| 2016 FY | 22.35 Billion CHF | -3.85% |
| 2015 FY | 23.25 Billion CHF | -9.58% |
| 2015 Q2 | 24.1 Billion CHF | 0.0% |
| 2015 Q4 | 23.25 Billion CHF | -0.03% |
| 2015 Q3 | 23.25 Billion CHF | -3.51% |
| 2015 Q1 | 24.1 Billion CHF | -6.27% |
| 2014 Q1 | 19.06 Billion CHF | 2.26% |
| 2014 Q3 | 25.72 Billion CHF | 34.93% |
| 2014 Q2 | 19.06 Billion CHF | 0.0% |
| 2014 FY | 25.71 Billion CHF | 37.93% |
| 2014 Q4 | 25.71 Billion CHF | -0.03% |
| 2013 FY | 18.64 Billion CHF | -24.18% |
| 2013 Q2 | 21.38 Billion CHF | 0.0% |
| 2013 Q4 | 18.64 Billion CHF | -0.21% |
| 2013 Q3 | 18.68 Billion CHF | -12.62% |
| 2013 Q1 | 21.38 Billion CHF | -13.05% |
| 2012 Q4 | 24.59 Billion CHF | 0.0% |
| 2012 Q2 | 26.55 Billion CHF | 0.0% |
| 2012 FY | 24.59 Billion CHF | -8.43% |
| 2011 Q2 | 26.22 Billion CHF | 0.0% |
| 2011 FY | 26.85 Billion CHF | -10.66% |
| 2011 Q4 | 26.85 Billion CHF | 0.0% |
| 2010 FY | 30.05 Billion CHF | -29.14% |
| 2010 Q2 | 36.44 Billion CHF | 0.0% |
| 2010 Q4 | 30.05 Billion CHF | 0.0% |
| 2009 Q4 | 42.41 Billion CHF | 0.0% |
| 2009 Q2 | 51.8 Billion CHF | 0.0% |
| 2009 FY | 42.41 Billion CHF | 937.32% |
| 2008 Q2 | 5.59 Billion CHF | 0.0% |
| 2008 FY | 4.08 Billion CHF | -40.45% |
| 2008 Q4 | 4.08 Billion CHF | 0.0% |
| 2007 Q2 | 7.63 Billion CHF | 0.0% |
| 2007 FY | 6.86 Billion CHF | -16.71% |
| 2007 Q4 | 6.86 Billion CHF | 0.0% |
| 2006 Q4 | 8.24 Billion CHF | 0.0% |
| 2006 FY | 8.24 Billion CHF | -14.76% |
| 2005 FY | 9.67 Billion CHF | 7.92% |
| 2004 FY | 8.96 Billion CHF | -41.39% |
| 2003 FY | 15.28 Billion CHF | -31.6% |
| 2002 FY | 22.35 Billion CHF | -5.82% |
| 2001 FY | 23.73 Billion CHF | 9.77% |
| 2000 FY | 21.61 Billion CHF | -11.12% |
| 1999 FY | 24.32 Billion CHF | 20.97% |
| 1998 FY | 20.1 Billion CHF | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AstraZeneca PLC | 28.58 Billion USD | -7.699% |
| Bristol-Myers Squibb Company PFD CONV 2 | 41.46 Billion USD | 25.762% |
| CSPC Pharmaceutical Group Limited | 99.64 Million USD | -30791.363% |
| Clarus Therapeutics Holdings, Inc. | 42.26 Million USD | -72724.055% |
| Novartis AG | 26.34 Billion USD | -16.829% |
| PT Kalbe Farma Tbk. | 40.4 Million USD | -76082.2% |